Your search history is turned on.
Date: May 3, 2024 Jurisdictions: All jurisdictions
-1- MEDICUS PHARMA LTD. ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Toronto, Ontario May 3rd, 2024 Medicus Pharma Ltd. (TSXV: MDCX) (FRA:N46) (the Company) is pleased to announce that it has completed the first closing of its previou...
Date: May 1, 2024 Jurisdictions: All jurisdictions
Aranjin Resources LTD - NoMRD.pdf Annual General and Special Meeting June 25, 2024 May 21, 2024 May 21, 2024 May 21, 2024 Common Shares CA58471K1030 Yes No No No Yours truly, Odyssey Trust Company as agent for Medicus Pharma Ltd May 1, 2024 Notice and Access for Beneficial Holders: Issuer sending proxy materials directly to NOBOs: Issuer paying for deliver...
Date: April 30, 2024 Jurisdictions: All jurisdictions
WSLEGAL\094076\00001\32398158v1 1 FORM 52-109F1R CERTIFICATION OF REFILED ANNUAL FILINGS This certificate is being filed on the same date that Medicus Pharma Ltd. (the "issuer") has refiled the annual financial statements and MD&A of the issuer for the financial year ended December 31, 2023. I, James Quinlan, Chief Financial Officer of Medicus Pharma Ltd., cer...
WSLEGAL\094076\00001\32398158v1 1 FORM 52-109F1R CERTIFICATION OF REFILED ANNUAL FILINGS This certificate is being filed on the same date that Medicus Pharma Ltd. (the "issuer") has refiled the annual financial statements and MD&A of the issuer for the financial year ended December 31, 2023. I, Dr. Raza Bokhari, Chief Executive Officer of Medicus Pharma Ltd., ...
GeneTether - Preliminary Prospectus (03136021.DOCX;3) MANAGEMENTS DISCUSSION AND ANALYSIS The following managements discussion and analysis (MD&A) of results of operations and financial conditions of Medicus Pharma Ltd. (Medicus, the Company, we, our, us and similar expressions), formerly Interactive Capital Partners Corporation (I...
Medicus Pharma Ltd. Consolidated Financial Statements For the years ended December 31, 2023 and 2022 (expressed in United States dollars, except number of shares) Note to Reader The annual financial statements are being refiled to include the auditors report which was erroneously omitted from the previous version. We have also corrected a typographical error o...
Date: April 29, 2024 Jurisdictions: All jurisdictions
Medicus Pharma Ltd. Consolidated Financial Statements For the years ended December 31, 2023 and 2022 (expressed in United States dollars, except number of shares) 2 Medicus Pharma Ltd. Consolidated Statements of Financial Position (expressed in United States dollars) As at December 31, 2023 December 31, 2022 Notes...
1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, James Quinlan, Chief Financial Officer of Medicus Pharma Ltd., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by refer...
1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Dr. Raza Bokhari, Chief Executive Officer of Medicus Pharma Ltd., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by re...
MANAGEMENTS DISCUSSION AND ANALYSIS The following managements discussion and analysis (MD&A) of results of operations and financial conditions of Medicus Pharma Ltd. (Medicus, the Company, we, our, us and similar expressions), formerly Interactive Capital Partners Corporation (Interactive), has been prepared as of April 29, 2024, and should be ...